Avadel Pharmaceuticals plc each representing one Ordinary Share (AVDL): Price and Financial Metrics


Avadel Pharmaceuticals plc each representing one Ordinary Share (AVDL): $2.57

0.13 (+5.33%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

AVDL Stock Price Chart Interactive Chart >

Price chart for AVDL

AVDL Price/Volume Stats

Current price $2.57 52-week high $11.59
Prev. close $2.44 52-week low $1.05
Day low $2.37 Volume 522,100
Day high $2.57 Avg. volume 2,191,342
50-day MA $3.39 Dividend yield N/A
200-day MA $6.83 Market Cap 151.73M

Avadel Pharmaceuticals plc each representing one Ordinary Share (AVDL) Company Bio


Avadel Pharmaceuticals plc develops and commercializes pharmaceutical products based on its proprietary drug delivery technology for primary care and sterile injectable markets in the United States, France, and Ireland. The company was formerly known as Flamel Technologies SA and changed its name to Avadel Pharmaceuticals plc in January 2017. The company was founded in 1990 and is based in Dublin, Ireland.


AVDL Latest News Stream


Event/Time News Detail
Loading, please wait...

AVDL Latest Social Stream


Loading social stream, please wait...

View Full AVDL Social Stream

Latest AVDL News From Around the Web

Below are the latest news stories about Avadel Pharmaceuticals Plc that investors may wish to consider to help them evaluate AVDL as an investment opportunity.

Is Avadel Pharmaceuticals (NASDAQ:AVDL) A Risky Investment?

The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...

Yahoo | February 22, 2022

Avadel Pharmaceuticals Appoints Dr. Douglas Williamson as Chief Medical Officer

DUBLIN, Ireland, Feb. 14, 2022 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (Nasdaq: AVDL), a company focused on transforming medicines to transform lives, today announced the appointment of Douglas Williamson, MBChB, as Chief Medical Officer. “Doug is an outstanding addition to the Avadel leadership team given his extensive experience in the biopharmaceutical industry leading R&D, clinical development and medical affairs teams in the neuroscience field,” said Greg Divis, Chief Executive Offic

Yahoo | February 14, 2022

Avadel Pharmaceuticals to Present at the 11th Annual SVB Leerink Global Healthcare Conference

DUBLIN, Ireland, Feb. 10, 2022 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (Nasdaq: AVDL), a company focused on transforming medicines to transform lives, announced today that Greg Divis, Chief Executive Officer of Avadel, will participate in a fireside chat at the 11th Annual SVB Leerink Global Healthcare Conference on Thursday, February 17 at 1:40 p.m. ET. A live webcast of the fireside chat, as well as an archived recording, will be available on Avadel’s Investor Relations website, investo

Yahoo | February 10, 2022

Analysts Offer Insights on Healthcare Companies: Avadel Pharmaceuticals (AVDL) and Selecta Biosciences (SELB)

There's a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Avadel Pharmaceuticals (AVDL – Research Report) and Selecta Biosciences (SELB – Research Report) with bullish sentiments. Avadel Pharmaceuticals (AVDL) Needham analyst Ami Fadia maintained a Buy rating on Avadel Pharmaceuticals today and set a price target of $15.00. The company's shares closed last Monday at $6.92, close to its 52-week low of $6.29. According to TipRanks.

Christine Brown on TipRanks | January 11, 2022

A Bull Market Continues To Unfold On Avadel Pharmaceuticals plc (NASDAQ: AVDL), As It Continued To Rise 12.57% In Year-To-Date

During the last session, Avadel Pharmaceuticals plc (NASDAQ:AVDL)s traded shares were 0.66 million, with the beta value of the company hitting 1.11. At the end of the trading day, the stocks price was $7.52, reflecting an intraday loss of -3.47% or -$0.27. The 52-week high for the AVDL share is $11.59, that puts it down A Bull Market Continues To Unfold On Avadel Pharmaceuticals plc (NASDAQ: AVDL), As It Continued To Rise 12.57% In Year-To-Date Read More »

Marketing Sentinel | December 18, 2021

Read More 'AVDL' Stories Here

AVDL Price Returns

1-mo 4.05%
3-mo -61.53%
6-mo -68.35%
1-year -64.55%
3-year 21.23%
5-year -76.83%
YTD -68.19%
2021 20.96%
2020 -11.52%
2019 192.64%
2018 -68.54%
2017 -21.08%

Continue Researching AVDL

Want to see what other sources are saying about Avadel Pharmaceuticals Plc's financials and stock price? Try the links below:

Avadel Pharmaceuticals Plc (AVDL) Stock Price | Nasdaq
Avadel Pharmaceuticals Plc (AVDL) Stock Quote, History and News - Yahoo Finance
Avadel Pharmaceuticals Plc (AVDL) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.4187 seconds.